Ocaperidone

This classification denotes an antipsychotic agent with the molecular formula C24H25FN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 26HUS7139V, chemically known as 4h-pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-2,9-dimethyl- but generally known as ocaperidone, which bears US NIH Compound Identifier 71351. European Medicines Agency schedules Ocaperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09395MIG. The term OCAPERIDONE is an International Non-Proprietary Name. OCAPERIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ocaperidone under HS 29349990 and SITC 51579. As of Q4 2014, OCAPERIDONE remains the US FDA Preferred Term for this commodity. Ocaperidone bears US NLM identifiers UMLS ID C0133602 and NCI Concept Code C76441. SMILES: FC1CC2ONC(C3CCN(CC3)CCC3C(NC4N(C3=O)CCCC4C)C)C2CC1.